Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenn N Levine

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Circulation|October 22, 2019
The Mind-Heart-Body ConnectionGlenn N Levine
JAMA Cardiology|April 30, 2020
Toward a More Detailed Reporting of MI Reduction in Clinical Trials-A Welcome and Needed Step in the Right DirectionGlenn N Levine
Polskie Archiwum Medycyny Wewnetrznej|April 15, 2008
Weighing the benefits and risks of magnetic resonance scanning of patients with implanted cardiovascular devicesGlenn N Levine
Trends in Cardiovascular Medicine|August 8, 2016
Editorial commentary: The continuing evolution of primary PCI and clinical guidelinesGlenn N Levine
JAMA|July 12, 2017
Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet TherapyGlenn N Levine
The American Journal of Medicine|March 12, 2022
Psychological Stress and Heart Disease: Fact or Folklore?Glenn N Levine
Journal of the American College of Cardiology|January 17, 2024
Erectile Dysfunction and Coronary Artery Disease: Unfortunate BedfellowsGlenn N Levine
Journal of Thrombosis and Thrombolysis|September 9, 2004
Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with acute coronary syndromes undergoing early percutaneous coronary interventionGlenn N Levine, Tracy Ferrando
Circulation|June 21, 2017
It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy DebatesGlenn N Levine, Eric R Bates
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 1, 2003
Low-molecular-weight heparin during percutaneous coronary interventions: rationale, results, and recommendationsGlenn N Levine, James J Ferguson
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Circulation|October 22, 2019
The Mind-Heart-Body ConnectionGlenn N Levine
JAMA Cardiology|April 30, 2020
Toward a More Detailed Reporting of MI Reduction in Clinical Trials-A Welcome and Needed Step in the Right DirectionGlenn N Levine
Polskie Archiwum Medycyny Wewnetrznej|April 15, 2008
Weighing the benefits and risks of magnetic resonance scanning of patients with implanted cardiovascular devicesGlenn N Levine
Trends in Cardiovascular Medicine|August 8, 2016
Editorial commentary: The continuing evolution of primary PCI and clinical guidelinesGlenn N Levine
JAMA|July 12, 2017
Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet TherapyGlenn N Levine
The American Journal of Medicine|March 12, 2022
Psychological Stress and Heart Disease: Fact or Folklore?Glenn N Levine
Journal of the American College of Cardiology|January 17, 2024
Erectile Dysfunction and Coronary Artery Disease: Unfortunate BedfellowsGlenn N Levine
Journal of Thrombosis and Thrombolysis|September 9, 2004
Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with acute coronary syndromes undergoing early percutaneous coronary interventionGlenn N Levine, Tracy Ferrando
Circulation|June 21, 2017
It Is Time to End the Dualistic Short Versus Long Duration of Dual Antiplatelet Therapy DebatesGlenn N Levine, Eric R Bates
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 1, 2003
Low-molecular-weight heparin during percutaneous coronary interventions: rationale, results, and recommendationsGlenn N Levine, James J Ferguson
Pageof 11